206 related articles for article (PubMed ID: 32458394)
1. Remission of ulcerative colitis flare-up induced by nivolumab.
Iwamoto M; Kato K; Moriyama M; Yamaguchi K; Takahashi S
Int J Colorectal Dis; 2020 Sep; 35(9):1791-1795. PubMed ID: 32458394
[TBL] [Abstract][Full Text] [Related]
2. [Colitis Suggested to be Related to Nivolumab in a Gastric Cancer Patient with a History of Ulcerative Colitis: A Case Report].
Ogawa T; Aimono Y; Saito Y; Yagisawa T; Iwayama T; Tamura A; Hirai S
Yakugaku Zasshi; 2024; 144(2):239-242. PubMed ID: 38296500
[TBL] [Abstract][Full Text] [Related]
3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
4. A case of nivolumab-associated colitis, which relapsed after mucosal healing and was then successfully treated with mesalazine.
Kikuchi H; Sakuraba H; Akemoto Y; Murai Y; Fukutoku Y; Asari T; Tatsuta T; Hasui K; Hiraga H; Sawaya M; Chinda D; Mikami T; Tanaka M; Fukuda S
Immunol Med; 2019 Mar; 42(1):39-44. PubMed ID: 30917094
[TBL] [Abstract][Full Text] [Related]
5. The characteristics of nivolumab-induced colitis: an evaluation of three cases and a literature review.
Yamauchi R; Araki T; Mitsuyama K; Tokito T; Ishii H; Yoshioka S; Kuwaki K; Mori A; Yoshimura T; Tsuruta O; Torimura T
BMC Gastroenterol; 2018 Aug; 18(1):135. PubMed ID: 30170560
[TBL] [Abstract][Full Text] [Related]
6. No increased risk of flare in ulcerative colitis patients in corticosteroid-free remission after stopping 5-aminosalicylic acid: A territory-wide population-based study.
Mak JWY; Yuen NTK; Yip TCF; Lam RHM; Lam BKH; Cheng CTY; Wong GLH; Chan FKL; Ng SC
J Gastroenterol Hepatol; 2022 Jul; 37(7):1284-1289. PubMed ID: 35338526
[TBL] [Abstract][Full Text] [Related]
7. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Marshall JK; Thabane M; Steinhart AH; Newman JR; Anand A; Irvine EJ
Cochrane Database Syst Rev; 2010 Jan; (1):CD004115. PubMed ID: 20091560
[TBL] [Abstract][Full Text] [Related]
8. Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis.
Bajpai M; Seril DN; Van Gurp J; Geng X; Alvarez J; Minacapelli CD; Gorin S; Das KK; Poplin E; Cheng J; Amenta PS; Das KM
Dig Dis Sci; 2019 Mar; 64(3):740-750. PubMed ID: 30478770
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive review and update on ulcerative colitis
Gajendran M; Loganathan P; Jimenez G; Catinella AP; Ng N; Umapathy C; Ziade N; Hashash JG
Dis Mon; 2019 Dec; 65(12):100851. PubMed ID: 30837080
[TBL] [Abstract][Full Text] [Related]
10. The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registry.
Fukuda T; Naganuma M; Sugimoto S; Nanki K; Mizuno S; Mutaguchi M; Nakazato Y; Inoue N; Ogata H; Iwao Y; Kanai T
PLoS One; 2017; 12(11):e0187737. PubMed ID: 29108025
[TBL] [Abstract][Full Text] [Related]
11. Safe Use of Nivolumab in a Patient with Epipharyngeal Carcinoma and Preexisting Ulcerative Colitis: A Histologically Proven Case Report.
Hijikata Y; Matsubara Y; Ota Y; Lim LA; Tani K; Hirata Y; Yotsuyanagi H
Intern Med; 2020 Apr; 59(8):1105-1109. PubMed ID: 32009094
[TBL] [Abstract][Full Text] [Related]
12. Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Marshall JK; Thabane M; Steinhart AH; Newman JR; Anand A; Irvine EJ
Cochrane Database Syst Rev; 2012 Nov; 11():CD004118. PubMed ID: 23152224
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Zhao X; Li N; Ren Y; Ma T; Wang C; Wang J; You S
PLoS One; 2016; 11(8):e0160500. PubMed ID: 27501314
[TBL] [Abstract][Full Text] [Related]
14. Mucosal concentrations of N-acetyl-5-aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine.
Fukuda T; Naganuma M; Takabayashi K; Hagihara Y; Tanemoto S; Nomura E; Yoshimatsu Y; Sugimoto S; Nanki K; Mizuno S; Mikami Y; Fukuhara K; Sujino T; Mutaguchi M; Inoue N; Ogata H; Iwao Y; Abe T; Kanai T
J Gastroenterol Hepatol; 2020 Nov; 35(11):1878-1885. PubMed ID: 32250471
[TBL] [Abstract][Full Text] [Related]
15. [Drug therapy for ulcerative colitis: salazosulfapyridine and 5-ASA].
Jo Y; Matsumoto T; Iida M
Nihon Rinsho; 2005 May; 63(5):820-4. PubMed ID: 15881176
[TBL] [Abstract][Full Text] [Related]
16. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
[TBL] [Abstract][Full Text] [Related]
17. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
18. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
[TBL] [Abstract][Full Text] [Related]
19. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial.
Lang A; Salomon N; Wu JC; Kopylov U; Lahat A; Har-Noy O; Ching JY; Cheong PK; Avidan B; Gamus D; Kaimakliotis I; Eliakim R; Ng SC; Ben-Horin S
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1444-9.e1. PubMed ID: 25724700
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
Cohen RD; Woseth DM; Thisted RA; Hanauer SB
Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
